We have studied the effects of human alphafetoprotein (HAFP), isolated from the serum and ascitic fluid of a hepatoma-bearing patient, on the in vitro transformation of human peripheral blood lymphocytes by a variety of mitogenic stimuli. At a concentration of 2.5 mg/ml, HAFP inhibited the Iymphocyte response to phytohemagglutinin, concanavalin A, and rabbit anti-human thymocyte serum, but failed to inhibit the response to pokeweed mitogen. HAFP Until recently, little was known of the biological role of the alpha-fetoprotein (1), although it was regarded as an embryonic serum albumin (2, 3) and was shown to possess estrogen hormone-binding properties (4). Our report on the inhibition of human lymphocyte transformation in vitro by fetuin (5), a bovine alpha-fetoprotein, and the simultaneous observations by Tomasi and his coworkers that murine alpha-fetoprotein suppresses murine lymphocyte responses in vitro to both mitogenic and antigenic stimuli (6, 7), suggest an immunoregulatory role for alpha-fetoproteins during fetal development. This paper presents experimental data that demonstrate the inhibitory effects of human alpha-fetoprotein (HAFP) on lymphocyte responses in vitro to a variety of mitogenic stimuli which include the one-way mixed lymphocytes culture. The results suggest that this effect may be due primarily to an inhibition of thymus-derived lymphocytic (T-lymphocyte) function.
250-500 Ag/ml, but failed to inhibit at 100 ;g/mL Exposure of lymphocytes to 2.2 mg/ml of HAFP for 18 hr did not result in significant lymphocytotoxicity, and such cells washed free of HAFP were fully capable of participating in the mixed lymphocyte culture. HAFP did not inhibit lymphocyte E-rosette formation. Fetal HAFP was more effective in inhibiting human lymphocyte responses than hepatoma HAFP. These experiments support the suggestion that HAFP plays an important immunoregulatory role during fetal development, possibly through the suppression of thymus-derived lymphocyte responses to antigenic stimuli; they also suggest that there are important differences in the biological properties of hepatoma and fetal HAFP. Until recently, little was known of the biological role of the alpha-fetoprotein (1), although it was regarded as an embryonic serum albumin (2, 3) and was shown to possess estrogen hormone-binding properties (4) . Our report on the inhibition of human lymphocyte transformation in vitro by fetuin (5), a bovine alpha-fetoprotein, and the simultaneous observations by Tomasi and his coworkers that murine alpha-fetoprotein suppresses murine lymphocyte responses in vitro to both mitogenic and antigenic stimuli (6, 7) , suggest an immunoregulatory role for alpha-fetoproteins during fetal development. This paper presents experimental data that demonstrate the inhibitory effects of human alpha-fetoprotein (HAFP) on lymphocyte responses in vitro to a variety of mitogenic stimuli which include the one-way mixed lymphocytes culture. The results suggest that this effect may be due primarily to an inhibition of thymus-derived lymphocytic (T-lymphocyte) function.
MATERIALS AND METHODS
The techniques for isolating, culturing, and harvesting cultures of human lymphocytes were previously described (5, (8) (9) (10) . A 1 ml culture system was employed throughout, and all experiments with cultures were performed in triplicate. The effect of preexposure with HAFP on the viability of human lymphocytes was determined by trypan blue exclusion (5) , and their ability to undergo subsequent transformation when subjected to a mitogenic stimulus was assessed. Lymphocytes (25-35 X 106), in a total volume of 2.0 ml of RPMI medium and 12.5% of human type AB serum, were incubated for 18 hr in the presence of 2.2 mg/ml of HAFP or HSA, with conditions identical to those used for lymphocyte cultures. A portion (4 X 106) of the lymphocytes was removed from the cell suspensions, spun down, and used for the determination of viability by the trypan blue method. The remainder of the cell suspension was diluted with 5 ml of Amos A gelatin (9) buffer and centrifuged at 150 X g for 15 min. The cell buttons were washed once more with 7 ml of Amos buffer, resuspended in culture medium, and used for transformation studies.
The ability of HAFP to inhibit E-rosette formation by Ficoll-Hypaque-isolated human lymphocytes was determined by means of the E-rosette formation procedure, carried out in the presence of 2.5 mg/ml of HAFP . This procedure was similar to one already described (13) , except that heat-inactivated human serum (type AB), previously absorbed with sheep red blood cells, was used in place of fetal calf serum.
In addition to the effect of HAFP in the mixed lymphocyte culture (MLC), the effect of HAFP on lymphocyte transformation by a nonhemagglutinating phytohemagglutinin (L-PHAP), concanavalin A (Con A), pokeweed mitogen (PWM), and rabbit anti-human thymocyte serum (ATS) was studied. The source and method of preparation of these mitogens have been described previously (5) . The following amounts of mitogen were used in all experiments, unless otherwise indicated: L-PHAP, 10 jig; Con A, 100,gg; PWM, 0.08,sg; and ATS, 25 yl. the lymphocyte responses to the other three mitogens, however, were significantly depressed (Fig. 1) . When resting human lymphocytes isolated by the FicollHypaque technique were cultured in the presence of 200-500 ,gg/ml of HAFP for 138 hr, significant inhibition of thymidine incorporation by the cells was frequently noted. The presence of HAFP in the culture medium at similar concentrations also resulted in marked suppression of the human one-way MLC. The inhibitory effects of HAFP were no longer apparent at a concentration of 100 ,gg/ml (Fig. 2) (Table   4) .
DISCUSSION
Our studies demonstrate that HAFP is capable of inhibiting in vitro transformation of human lymphocytes induced by phytomitogens, ATS, and allogeneic human lymphocytes. In this respect, the behavior of HAFP is similar to that which we have described for fetuin, a bovine alpha-fetoprotein (5); its inhibitory effects also resemble those of murine alpha-fetoprotein on murine lymphocyte transformation (7). Our observation on the relatively high concentrations of hepatoma HAFP (equivalent to those of fetuin) required for human lymphocyte suppression in vitro as opposed to murine alpha-fetoprotein, suggests that inhibition at low concentrations may not be a universal characteristic of this alpha-fetoprotein effect. The variability may be due to species differences, alterations of the protein during isolation, the presence or absence of small low-molecular-weight materials bound to the protein, or to special characteristics of HAFP derived from fetuses as opposed to hepatoma-bearing adults (see below).
Since HAFP is a glycoprotein (11), the possibility that it inhibits phytomitogen-induced lymphocyte transformation by association with the mitogenic agent must be considered (5, 14) . We have not studied these possible interactions in detail, but others have described the binding of some HAFP molecules to Con A in free solution as well as to Con A immobilized on Sepharose beads (15) . We have failed to demonstrate any precipitation when HAFP and L-PHAP or hemagglutinating phyto-hemagglutinin (H-PHAP) are allowed to diffuse toward one another in an Ouchterlony plate. As in the case of fetuin (5), the most compelling evidence against the possibility that HAFP competes with the responding lymphocyte for the mitogenic stimulus is that the most potent inhibitory effects of HAFP are manifest in the one-way MLC, where the mitogenic stimulus is due to the structural difference between allogeneic cell surface membranes. The failure of HAFP to cause nonspecific lymphocytotoxicity as measured by trypan blue exclusion following an 18 hr incubation suggests that nonspecific cell death also plays little or no role in HAFP inhibition of lymphocyte transformation. This conclusion is also borne out by the differential HAFP inhibition of lymphocytes stimulated by a variety of mitogens; if nonspecific cell death were the explanation of the inhibiting effect from HAFP, all mitogens (Con A, PWM, L-PHAP, and ATS) should have been affected equally. Further evidence for the lack of nonspecific HAFP lymphocytotoxicity is HAFP failure to inhibit the MLC when the cells involved were preincubated with HAFP for 18 hr and washed free of the protein prior to initiation of the MLC, although the concentrations of HAFP used during the preexposure were 5-to 10-fold higher than that required for inhibition when HAFP was present during the entire MLC incubation. HAFP derived from the hepatoma patient does not adversely affect resting-lymphocyte DNA synthesis in short-term cultures of column-purified lymphocytes. However, significant depression of resting-lymphocyte thymidine incorporation by HAFP was usually observed in longer-term control cultures of Ficoll-Hypaque-isolated mononuclear cells during MLC experiments. The suppression of nonstimulated lymphocyte responses by HAFP occurs predominantly in longer-term lymphocyte cultures which are, by comparison with the short-term lymphocyte cultures prepared by nylon column-passage, proportionately richer in bone marrow derived lymphocytes (Blymphocytes) (16) . This suggests that HAFP may, in fact, suppress T-lymphocyte responses to autologous B-lymphocyte surface determinants (17) . Such a conclusion would be justified by the results of our studies; human lymphocyte responses to mitogens including Con A, L-PHAP, ATS, and the MLC, all of which are primarily or exclusively due to T-lymphocyte cell proliferation (18) (19) (20) (21) (22) , were suppressed by HAFP, whereas the mitogenic effect of PWM, an effective B-lymphocyte stimulus (18, 19, 22, 23) , was relatively resistant to such inhibition. The suppression of PWM-induced lymphocyte transformation by fetal HAFP may be due in part to the fact that T-lymphocyte proliferation can be induced by PWM, and may be required to enhance B-lymphocyte responses to PWM. Thus, the im- munosuppressive effects of HAFP are probably selective, and are directed primarily to the T-lymphocyte population; a similar conclusion has been reached by Tomasi and his coworkers regarding murine alpha-fetoprotein (6, 7) . Despite the capacity of HAFP to inhibit T-lymphocyte response to mitogens, HAFP lacks the ability to inhibit E-rosette formation (24) .
A marked difference was found between the capacities of fetal HAFP and hepatoma HAFP to inhibit lymphocyte responses. In addition, fetal HAFP more profoundly inhibited DNA synthesis by resting lymphocytes. One might argue that these differences reflect denaturation of hepatoma HAFP by our isolation procedures; however, precisely the same techniques were used for isolation of both proteins. Differences in primary amino acid sequence or in carbohydrate side chains could also be responsible for this difference in biologic potency (3, (25) (26) (27) ), but we could elicit no evidence for such alterations by electrophoretic behavior or immunologic characteristicst (28) , and others have found the amino acid and sugar composition of fetal and hepatoma HAFP to be almost indistinguishable (11, 29) . The possibility remains that the greater inhibitory effects of fetal versus hepatoma HAFP may be due to some low-molecular-weight molecule bound to fetal HAFP that emerges from a different biological environment 
